← All companies
Twist Bioscience Corp
TWST - CIK 0001581280
Market cap$4.22 B
Rank#1523
SEC filings1,496
The table below shows Twist Bioscience Corp's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | $53.59M | $49.73M | $44.76M | $46.77M | $45.87M | $46.19M |
| Gross profit | - | - | - | - | - | - |
| R&D | $19.70M | $17.13M | $18.05M | $23.92M | $21.31M | $22.47M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.